...
首页> 外文期刊>Japanese journal of radiology >Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: Imaging findings and prevalence in various hepatobiliary diseases
【24h】

Intrahepatic periportal high intensity on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI: Imaging findings and prevalence in various hepatobiliary diseases

机译:Gd-EOB-DTPA增强MRI的肝胆期图像上的肝内门静脉高强度:各种肝胆疾病的影像学发现和患病率

获取原文
获取原文并翻译 | 示例

摘要

Purpose: To reveal the incidence and degree of intrahepatic periportal high intensity (PHI) on hepatobiliary phase images of Gd-EOB-DTPA-enhanced MRI (EOB-MRI) in patients with or without various hepatobiliary diseases. Materials and methods: Patients with normal liver (N = 256) and those with hepatic disorder (N = 857) who underwent EOB-MRI were the subjects in this study. Incidence of PHI was evaluated among the patients with normal liver and those with hepatic disorder. Degree of PHI was categorized into four grades and compared among the various hepatic diseases. Enhancement ratios (ER) of the PHI area, background liver with PHI, and background liver in control cases without PHI were evaluated. Results: PHI was observed in 2.7 % of the patients with hepatic disorder. No PHI was observed in the patients with normal liver. The incidence rates of PHI among various hepatobiliary diseases were as follows; liver cirrhosis 3.1 %, chronic hepatitis 1.0 %, primary biliary cirrhosis 12.5 %, idiopathic portal hypertension 33.3 %. The ER of the PHI area and background liver were 3.92 and 2.48 (p = 0.0002). There were no significant differences between the ER of the PHI area and the ER of background liver in the noncirrhotic control without PHI. Conclusion: In 2.7 % of the patients with a hepatic disorder, the periportal area was saved from decrease of EOB uptake and it showed PHI.
机译:目的:揭示Gd-EOB-DTPA增强MRI(EOB-MRI)在有或无各种肝胆疾病患者中的肝胆期相高强度(PHI)的发生率和程度。材料和方法:接受EOB-MRI检查的正常肝患者(N = 256)和肝病患者(N = 857)是本研究的对象。评估了正常肝和肝病患者的PHI发病率。 PHI的等级分为四个等级,并在各种肝病之间进行比较。评估了PHI区域,有PHI的背景肝脏和无PHI的对照病例的背景肝脏的增强率(ER)。结果:2.7%的肝病患者中观察到PHI。正常肝患者未观察到PHI。各种肝胆疾病中PHI的发生率如下:肝硬化3.1%,慢性肝炎1.0%,原发性胆汁性肝硬化12.5%,特发性门脉高压33.3%。 PHI和背景肝脏的ER为3.92和2.48(p = 0.0002)。在没有PHI的非肝硬化对照组中,PHI区的ER与背景肝脏的ER之间没有显着差异。结论:2.7%的肝病患者中,由于EOB摄取减少而保留了门静脉周围区域,并显示PHI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号